• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性硬化症患者的全血血小板聚集和凝血因子

Whole blood platelet aggregation and coagulation factors in patients with systemic sclerosis.

作者信息

Goodfield M J, Orchard M A, Rowell N R

机构信息

Department of Dermatology, General Infirmary, Leeds.

出版信息

Br J Haematol. 1993 Aug;84(4):675-80. doi: 10.1111/j.1365-2141.1993.tb03145.x.

DOI:10.1111/j.1365-2141.1993.tb03145.x
PMID:8217827
Abstract

It is unclear whether the changes in platelet function which are observed in systemic sclerosis are a primary characteristic of this disease or whether they occur secondary to vascular changes. Whole blood platelet aggregation was studied in 26 patients with systemic sclerosis, normal subjects matched for age, sex and secondary characteristics, 19 patients with Raynaud's disease and 19 patients with systemic lupus erythematosus. Plasma levels of fibrinogen, von Willebrand factor antigen and factor VIII:C were also measured. Systemic sclerosis was associated with a significant (P > 0.001) enhancement of the sensitivity of platelets to collagen. In contrast, significant enhancement of the response to either ADP or adrenaline was not observed. Enhanced sensitivity to collagen was not associated with the presence of either Raynaud's disease or systemic lupus erythematosus. Systemic sclerosis was associated with significantly raised levels of von Willebrand factor antigen and fibrinogen. On an individual patient basis, von Willebrand factor antigen was related to the severity of the disease whereas platelet sensitivity to collagen was not. In conclusion, this study suggests that the enhanced sensitivity to collagen which occurs in systemic sclerosis is due to a primary change in the platelet and that this change can combine with elevated levels of adhesive proteins.

摘要

目前尚不清楚系统性硬化症中观察到的血小板功能变化是该疾病的主要特征,还是继发于血管变化。对26例系统性硬化症患者、年龄、性别和次要特征相匹配的正常受试者、19例雷诺病患者和19例系统性红斑狼疮患者进行了全血血小板聚集研究。还测量了血浆纤维蛋白原、血管性血友病因子抗原和因子VIII:C水平。系统性硬化症与血小板对胶原蛋白敏感性的显著增强(P>0.001)相关。相比之下,未观察到对ADP或肾上腺素反应的显著增强。对胶原蛋白的敏感性增强与雷诺病或系统性红斑狼疮的存在无关。系统性硬化症与血管性血友病因子抗原和纤维蛋白原水平的显著升高相关。在个体患者中,血管性血友病因子抗原与疾病严重程度相关,而血小板对胶原蛋白的敏感性则不然。总之,本研究表明,系统性硬化症中出现的对胶原蛋白敏感性增强是由于血小板的原发性变化,并且这种变化可与粘附蛋白水平升高相结合。

相似文献

1
Whole blood platelet aggregation and coagulation factors in patients with systemic sclerosis.系统性硬化症患者的全血血小板聚集和凝血因子
Br J Haematol. 1993 Aug;84(4):675-80. doi: 10.1111/j.1365-2141.1993.tb03145.x.
2
Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in scleroderma and in Raynaud's phenomenon.硬皮病和雷诺现象中因子VIII/血管性血友病因子抗原及血管性血友病因子活性增加。
Ann Intern Med. 1981 Apr;94(4 pt 1):482-4. doi: 10.7326/0003-4819-94-4-482.
3
In vitro platelet aggregability studies: lack of evidence for platelet hyperactivity in systemic sclerosis.体外血小板聚集性研究:系统性硬化症中缺乏血小板活性过高的证据。
Ann Rheum Dis. 1991 Aug;50(8):567-71. doi: 10.1136/ard.50.8.567.
4
Increased whole blood platelet aggregation in patients with Raynaud's phenomenon with or without systemic sclerosis.患有或未患有系统性硬化症的雷诺现象患者全血血小板聚集增加。
Scand J Rheumatol. 1993;22(3):97-101. doi: 10.3109/03009749309099251.
5
Increased platelet sensitivity to collagen-induced aggregation in whole blood patients with systemic sclerosis.系统性硬化症全血患者血小板对胶原诱导聚集的敏感性增加。
Clin Exp Rheumatol. 1988 Jul-Sep;6(3):285-8.
6
Effect of insulin treatment in streptozocin-induced diabetic rats on in vitro platelet function and plasma von Willebrand factor activity and factor VIII-related antigen.胰岛素治疗对链脲佐菌素诱导的糖尿病大鼠体外血小板功能、血浆血管性血友病因子活性及因子VIII相关抗原的影响。
J Lab Clin Med. 1985 Sep;106(3):319-25.
7
Time course of changes in in vitro platelet function and plasma von willebrand factor activity (VIIIR:WF) and factor VIII-related antigen (VIIIR:Ag) in the diabetic rat.糖尿病大鼠体外血小板功能及血浆血管性血友病因子活性(VIIIR:WF)和因子VIII相关抗原(VIIIR:Ag)变化的时间进程。
J Lab Clin Med. 1983 Nov;102(5):795-804.
8
The clinical significance of coagulation abnormalities in systemic sclerosis (scleroderma).系统性硬化症(硬皮病)中凝血异常的临床意义。
J Rheumatol. 1985 Jun;12(3):514-7.
9
Increased platelet function and von Willebrand factor in vibration syndrome.振动综合征中血小板功能和血管性血友病因子增加。
Tokushima J Exp Med. 1980 Jun;27(1-2):23-8.
10
[Multimeric structure of factor VIII/von Willebrand factor released from human platelets by ADP, collagen and thrombin].
Sangre (Barc). 1983;28(4):439-49.

引用本文的文献

1
Role of Alarmins in the Pathogenesis of Systemic Sclerosis.警报素在系统性硬化症发病机制中的作用。
Int J Mol Sci. 2020 Jul 15;21(14):4985. doi: 10.3390/ijms21144985.
2
Whole-Body Distribution and Clinical Association of Telangiectases in Systemic Sclerosis.全身性硬皮病的毛细血管扩张症的全身分布与临床相关性。
JAMA Dermatol. 2018 Jul 1;154(7):796-805. doi: 10.1001/jamadermatol.2018.0916.
3
Pathogenesis of Systemic Sclerosis.系统性硬化症的发病机制
Front Immunol. 2015 Jun 8;6:272. doi: 10.3389/fimmu.2015.00272. eCollection 2015.
4
The role of platelets in the pathogenesis of systemic sclerosis.血小板在系统性硬化症发病机制中的作用。
Front Immunol. 2012 Jun 18;3:160. doi: 10.3389/fimmu.2012.00160. eCollection 2012.
5
Vascular involvement in systemic sclerosis (scleroderma).系统性硬皮病(硬皮病)中的血管病变。
J Inflamm Res. 2011;4:105-25. doi: 10.2147/JIR.S18145. Epub 2011 Jul 26.
6
Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis.原发性雷诺现象和系统性硬化症中的血管性血友病因子、血栓调节蛋白、血栓素、β-血小板球蛋白及纤维蛋白溶解标志物
Ann Rheum Dis. 1996 Feb;55(2):122-7. doi: 10.1136/ard.55.2.122.